COVID-19 Impact on Global Meningococcal Infections Treatment Market Size, Status and Forecast 2020-2026

July 2020 | 96 pages | ID: CCADBEFA27AFEN
QYResearch

Abstracts

This report focuses on the global Meningococcal Infections Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Meningococcal Infections Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Pfizer
• Sanofi
• GlaxoSmithKline
• Novartis

Market segment by Type, the product can be split into

• Antibiotics
• Glucocorticoids
• Protein C Concentrate

Market segment by Application, split into

• Hospitals
• Clinics
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Meningococcal Infections Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Meningococcal Infections Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Meningococcal Infections Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Meningococcal Infections Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Meningococcal Infections Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Antibiotics
  1.4.3 Glucocorticoids
  1.4.4 Protein C Concentrate
1.5 Market by Application
  1.5.1 Global Meningococcal Infections Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinics
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Meningococcal Infections Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Meningococcal Infections Treatment Industry
    1.6.1.1 Meningococcal Infections Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Meningococcal Infections Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Meningococcal Infections Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Meningococcal Infections Treatment Market Perspective (2015-2026)
2.2 Meningococcal Infections Treatment Growth Trends by Regions
  2.2.1 Meningococcal Infections Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Meningococcal Infections Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Meningococcal Infections Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Meningococcal Infections Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Meningococcal Infections Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Meningococcal Infections Treatment Players by Market Size
  3.1.1 Global Top Meningococcal Infections Treatment Players by Revenue (2015-2020)
  3.1.2 Global Meningococcal Infections Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Meningococcal Infections Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Meningococcal Infections Treatment Market Concentration Ratio
  3.2.1 Global Meningococcal Infections Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Meningococcal Infections Treatment Revenue in 2019
3.3 Meningococcal Infections Treatment Key Players Head office and Area Served
3.4 Key Players Meningococcal Infections Treatment Product Solution and Service
3.5 Date of Enter into Meningococcal Infections Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Meningococcal Infections Treatment Historic Market Size by Type (2015-2020)
4.2 Global Meningococcal Infections Treatment Forecasted Market Size by Type (2021-2026)

5 MENINGOCOCCAL INFECTIONS TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Meningococcal Infections Treatment Market Size by Application (2015-2020)
5.2 Global Meningococcal Infections Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Meningococcal Infections Treatment Market Size (2015-2020)
6.2 Meningococcal Infections Treatment Key Players in North America (2019-2020)
6.3 North America Meningococcal Infections Treatment Market Size by Type (2015-2020)
6.4 North America Meningococcal Infections Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Meningococcal Infections Treatment Market Size (2015-2020)
7.2 Meningococcal Infections Treatment Key Players in Europe (2019-2020)
7.3 Europe Meningococcal Infections Treatment Market Size by Type (2015-2020)
7.4 Europe Meningococcal Infections Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Meningococcal Infections Treatment Market Size (2015-2020)
8.2 Meningococcal Infections Treatment Key Players in China (2019-2020)
8.3 China Meningococcal Infections Treatment Market Size by Type (2015-2020)
8.4 China Meningococcal Infections Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Meningococcal Infections Treatment Market Size (2015-2020)
9.2 Meningococcal Infections Treatment Key Players in Japan (2019-2020)
9.3 Japan Meningococcal Infections Treatment Market Size by Type (2015-2020)
9.4 Japan Meningococcal Infections Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Meningococcal Infections Treatment Market Size (2015-2020)
10.2 Meningococcal Infections Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Meningococcal Infections Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Meningococcal Infections Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Meningococcal Infections Treatment Market Size (2015-2020)
11.2 Meningococcal Infections Treatment Key Players in India (2019-2020)
11.3 India Meningococcal Infections Treatment Market Size by Type (2015-2020)
11.4 India Meningococcal Infections Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Meningococcal Infections Treatment Market Size (2015-2020)
12.2 Meningococcal Infections Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Meningococcal Infections Treatment Market Size by Type (2015-2020)
12.4 Central & South America Meningococcal Infections Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Meningococcal Infections Treatment Introduction
  13.1.4 Pfizer Revenue in Meningococcal Infections Treatment Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 Sanofi
  13.2.1 Sanofi Company Details
  13.2.2 Sanofi Business Overview and Its Total Revenue
  13.2.3 Sanofi Meningococcal Infections Treatment Introduction
  13.2.4 Sanofi Revenue in Meningococcal Infections Treatment Business (2015-2020)
  13.2.5 Sanofi Recent Development
13.3 GlaxoSmithKline
  13.3.1 GlaxoSmithKline Company Details
  13.3.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.3.3 GlaxoSmithKline Meningococcal Infections Treatment Introduction
  13.3.4 GlaxoSmithKline Revenue in Meningococcal Infections Treatment Business (2015-2020)
  13.3.5 GlaxoSmithKline Recent Development
13.4 Novartis
  13.4.1 Novartis Company Details
  13.4.2 Novartis Business Overview and Its Total Revenue
  13.4.3 Novartis Meningococcal Infections Treatment Introduction
  13.4.4 Novartis Revenue in Meningococcal Infections Treatment Business (2015-2020)
  13.4.5 Novartis Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Meningococcal Infections Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Meningococcal Infections Treatment Revenue
Table 3. Ranking of Global Top Meningococcal Infections Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Meningococcal Infections Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Antibiotics
Table 6. Key Players of Glucocorticoids
Table 7. Key Players of Protein C Concentrate
Table 8. COVID-19 Impact Global Market: (Four Meningococcal Infections Treatment Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Meningococcal Infections Treatment Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Meningococcal Infections Treatment Players to Combat Covid-19 Impact
Table 13. Global Meningococcal Infections Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Meningococcal Infections Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Meningococcal Infections Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Meningococcal Infections Treatment Market Share by Regions (2015-2020)
Table 17. Global Meningococcal Infections Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Meningococcal Infections Treatment Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Meningococcal Infections Treatment Market Growth Strategy
Table 23. Main Points Interviewed from Key Meningococcal Infections Treatment Players
Table 24. Global Meningococcal Infections Treatment Revenue by Players (2015-2020) (Million US$)
Table 25. Global Meningococcal Infections Treatment Market Share by Players (2015-2020)
Table 26. Global Top Meningococcal Infections Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Infections Treatment as of 2019)
Table 27. Global Meningococcal Infections Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Meningococcal Infections Treatment Product Solution and Service
Table 30. Date of Enter into Meningococcal Infections Treatment Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Meningococcal Infections Treatment Market Size by Type (2015-2020) (Million US$)
Table 33. Global Meningococcal Infections Treatment Market Size Share by Type (2015-2020)
Table 34. Global Meningococcal Infections Treatment Revenue Market Share by Type (2021-2026)
Table 35. Global Meningococcal Infections Treatment Market Size Share by Application (2015-2020)
Table 36. Global Meningococcal Infections Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. Global Meningococcal Infections Treatment Market Size Share by Application (2021-2026)
Table 38. North America Key Players Meningococcal Infections Treatment Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Meningococcal Infections Treatment Market Share (2019-2020)
Table 40. North America Meningococcal Infections Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. North America Meningococcal Infections Treatment Market Share by Type (2015-2020)
Table 42. North America Meningococcal Infections Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. North America Meningococcal Infections Treatment Market Share by Application (2015-2020)
Table 44. Europe Key Players Meningococcal Infections Treatment Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Meningococcal Infections Treatment Market Share (2019-2020)
Table 46. Europe Meningococcal Infections Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Meningococcal Infections Treatment Market Share by Type (2015-2020)
Table 48. Europe Meningococcal Infections Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Meningococcal Infections Treatment Market Share by Application (2015-2020)
Table 50. China Key Players Meningococcal Infections Treatment Revenue (2019-2020) (Million US$)
Table 51. China Key Players Meningococcal Infections Treatment Market Share (2019-2020)
Table 52. China Meningococcal Infections Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. China Meningococcal Infections Treatment Market Share by Type (2015-2020)
Table 54. China Meningococcal Infections Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. China Meningococcal Infections Treatment Market Share by Application (2015-2020)
Table 56. Japan Key Players Meningococcal Infections Treatment Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Meningococcal Infections Treatment Market Share (2019-2020)
Table 58. Japan Meningococcal Infections Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Meningococcal Infections Treatment Market Share by Type (2015-2020)
Table 60. Japan Meningococcal Infections Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Meningococcal Infections Treatment Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Meningococcal Infections Treatment Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Meningococcal Infections Treatment Market Share (2019-2020)
Table 64. Southeast Asia Meningococcal Infections Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Meningococcal Infections Treatment Market Share by Type (2015-2020)
Table 66. Southeast Asia Meningococcal Infections Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Meningococcal Infections Treatment Market Share by Application (2015-2020)
Table 68. India Key Players Meningococcal Infections Treatment Revenue (2019-2020) (Million US$)
Table 69. India Key Players Meningococcal Infections Treatment Market Share (2019-2020)
Table 70. India Meningococcal Infections Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. India Meningococcal Infections Treatment Market Share by Type (2015-2020)
Table 72. India Meningococcal Infections Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. India Meningococcal Infections Treatment Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Meningococcal Infections Treatment Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Meningococcal Infections Treatment Market Share (2019-2020)
Table 76. Central & South America Meningococcal Infections Treatment Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Meningococcal Infections Treatment Market Share by Type (2015-2020)
Table 78. Central & South America Meningococcal Infections Treatment Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Meningococcal Infections Treatment Market Share by Application (2015-2020)
Table 80. Pfizer Company Details
Table 81. Pfizer Business Overview
Table 82. Pfizer Product
Table 83. Pfizer Revenue in Meningococcal Infections Treatment Business (2015-2020) (Million US$)
Table 84. Pfizer Recent Development
Table 85. Sanofi Company Details
Table 86. Sanofi Business Overview
Table 87. Sanofi Product
Table 88. Sanofi Revenue in Meningococcal Infections Treatment Business (2015-2020) (Million US$)
Table 89. Sanofi Recent Development
Table 90. GlaxoSmithKline Company Details
Table 91. GlaxoSmithKline Business Overview
Table 92. GlaxoSmithKline Product
Table 93. GlaxoSmithKline Revenue in Meningococcal Infections Treatment Business (2015-2020) (Million US$)
Table 94. GlaxoSmithKline Recent Development
Table 95. Novartis Company Details
Table 96. Novartis Business Overview
Table 97. Novartis Product
Table 98. Novartis Revenue in Meningococcal Infections Treatment Business (2015-2020) (Million US$)
Table 99. Novartis Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Meningococcal Infections Treatment Market Share by Type: 2020 VS 2026
Figure 2. Antibiotics Features
Figure 3. Glucocorticoids Features
Figure 4. Protein C Concentrate Features
Figure 5. Global Meningococcal Infections Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Meningococcal Infections Treatment Report Years Considered
Figure 10. Global Meningococcal Infections Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Meningococcal Infections Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Meningococcal Infections Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Meningococcal Infections Treatment Market Share by Players in 2019
Figure 15. Global Top Meningococcal Infections Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Infections Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Meningococcal Infections Treatment Revenue in 2019
Figure 17. North America Meningococcal Infections Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Meningococcal Infections Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Meningococcal Infections Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Meningococcal Infections Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Meningococcal Infections Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Meningococcal Infections Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Meningococcal Infections Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Pfizer Revenue Growth Rate in Meningococcal Infections Treatment Business (2015-2020)
Figure 26. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Sanofi Revenue Growth Rate in Meningococcal Infections Treatment Business (2015-2020)
Figure 28. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. GlaxoSmithKline Revenue Growth Rate in Meningococcal Infections Treatment Business (2015-2020)
Figure 30. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Novartis Revenue Growth Rate in Meningococcal Infections Treatment Business (2015-2020)
Figure 32. Bottom-up and Top-down Approaches for This Report
Figure 33. Data Triangulation
Figure 34. Key Executives Interviewed